Citations (4)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Chih-Chung Cheng, Hung-Chieh Yeh, Pei-Wen Su, Chien-Lin Ho & Sheng-Chi Chang. (2024) Risk factors of chronic kidney disease in cisplatin-based hyperthermia intraperitoneal chemotherapy. International Journal of Hyperthermia 41:1.
Read now
Read now
Articles from other publishers (3)
Ya-Fen Wang, Ting-Yao Wang, Tzu-Ting Liao, Meng-Hung Lin, Tzu-Hao Huang, Meng-Chiao Hsieh, Vincent Chin-Hung Chen, Li-Wen Lee, Wen-Shih Huang & Chao-Yu Chen. (2022) Quality of life and symptom distress after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. World Journal of Clinical Cases 10:32, pages 11775-11788.
Crossref
Crossref
Wei-Chun Chen, Ting-Chang Chang & Hung-Hsueh Chou. (2022) Reply: Serum CA-125 and renal impairment in patients undergoing hyperthermic intraperitoneal chemotherapy. Biomedical Journal 45:5, pages 849-850.
Crossref
Crossref
. (2021) Cisplatin. Reactions Weekly 1853:1, pages 133-133.
Crossref
Crossref